Prognostic factors affecting pancreatic adenocarcinoma
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Access through your institution Buy or subscribe Sagol Ö _et al_. (2005) The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic
carcinoma. _Pancreas_ 30: 343–348 Pancreatic cancer is an aggressive and intrinsically therapy-resistant and drug-resistant neoplasm, with consequently poor prognosis. In order to clarify
the underlying pathogenetic mechanisms of pancreatic adenocarcinoma, a group from Turkey has investigated the roles of apoptosis, SURVIVIN, tumor-cell proliferation and P-GLYCOPROTEIN in the
behavior of this disease. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print
issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to
local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support CHANGE HISTORY * _
17 MAY 2018 This article was published with the same DOI as a previous publication. A new DOI has been assigned and registered at Crossref, and has been corrected in the article. _ GLOSSARY
* SURVIVIN A member of the 'inhibitor of apoptosis' family of negative regulatory proteins that prevent apoptotic cell death; gene expression is high during fetal development and
in most tumors, but low in adult tissues * P-GLYCOPROTEIN An ATP-binding plasma membrane protein; overexpression confers multidrug resistance to tumor cells by expelling cytotoxic drugs
RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Prognostic factors affecting pancreatic adenocarcinoma. _Nat Rev Gastroenterol Hepatol_ 2, 345 (2005).
https://doi.org/10.1038/ncponc0242x Download citation * Issue Date: August 2005 * DOI: https://doi.org/10.1038/ncponc0242x SHARE THIS ARTICLE Anyone you share the following link with will be
able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing
initiative